Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 601–700 of 1,000
Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors
Sukumar, J. S., Raghavendra, A. S., Pasyar, S., Bassett, R. L., Tripathy, D., Barcenas, C. H., Basen‐Engquist, K., & Arun, B. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0554 · Cited by 12
“Observational data support that obesity in breast cancer survivors is associated with increased recurrence risk and mortality, demonstrated across disease sub-types (hormone positive and negative) and independent of menopausal status (3–5).”
Guo, Z., Wang, J., Tian, X., Fang, Z., Gao, Y., Ping, Z., & Liu, L. (2022) · Public Health · doi:10.1016/j.puhe.2022.06.014 · Cited by 12
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer
Peterson, L. L., & Ligibel, J. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188995 · Cited by 12
SenthilKumar, G., Schottstaedt, A. M., Peterson, L. L., Pedersen, L. N., Chitambar, C. R., Vistocky, A., Banerjee, A., Longo, J. M., Kelly, T. R., Currey, A. D., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0148 · Cited by 12
Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ
Veal, C. T., Hart, V., Gilchrist, S. C., Hampton, J. M., Gangnon, R. E., Newcomb, P. A., Higgins, S. T., Trentham‐Dietz, A., & Sprague, B. L. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0590-z · Cited by 12
Wu, R., Liu, T., Yang, P., Liu, X., Liu, F., Wang, Y., Xiong, H., Yu, S., Huang, X., & Zhuang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15280 · Cited by 12
“BMI at diagnosis was a statistically significant prognostic factor in women with early-stage breast cancer [24, 25].”
BackgroundLohmann, A. E., Dowling, R. J. O., Ennis, M., Amir, E., Elser, C., Brezden‐Masley, C., Vandenberg, T. A., Lee, E., Fazaee, K., Stambolic, V., et al. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky028 · Cited by 12
“Also, obesity and obesity-related markers, such as some inflammatory and metabolic variables, are associated with BC risk (3) and worse prognosis after diagnosis of early BC (4–6).”
BackgroundAnber, Z. N. H. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-18-1140 · Cited by 12
Arnould, L., Penault-Llorca, F. M., Dohollou, N., Caron, O., & Lévy, C. (2019) · Bulletin du Cancer · doi:10.1016/s0007-4551(20)30042-4 · Cited by 12
The core components of cardio-oncology rehabilitation
Venturini, E., Gilchrist, S. C., Corsi, E., Lorenzo, A. D., Cuomo, G., D’AMBROSIO, G., Pacileo, M., D’Andrea, A., Canale, M. L., Iannuzzo, G., et al. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04303-2 · Cited by 12
Prediction models for breast cancer prognosis among Asian women
Fan, R., Chen, Y., Nechuta, S., Cai, H., Gu, K., Shi, L., Bao, P., Shyr, Y., Shu, X., & Ye, F. (2021) · Cancer · doi:10.1002/cncr.33425 · Cited by 12
“9).(33) Physical activity is important throughout breast cancer treatment and survivorship.”
BackgroundLigibel, J. A., Huebner, L., Rugo, H. S., Burstein, H. J., Toppmeyer, D., Anders, C. K., Ma, C. X., Barry, W. T., Suman, V. J., Carey, L., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab025 · Cited by 12
“A meta-analysis conducted by the World Cancer Research Fund of 82 reports evaluating the relationship between body mass index (BMI) and mortality in women with stage I-III breast cancer reported a 35% increase in breast cancer–related mortality and a 41% increase in overall mortality in women with obesity at the time…”
BackgroundMethodReprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?
Mozihim, A. K., Chung, I., Said, N. A. B. M., & Jamil, A. H. A. (2022) · Metabolites · doi:10.3390/metabo12040350 · Cited by 12
“41 [153], while postmenopausal women who have gained 5–10 kg were at higher risk of breast cancer, with a hazard ratio of 1.”
BackgroundLiedtke, C., Thill, M., Hanf, V., & Schütz, F. (2015) · Breast Care · doi:10.1159/000431248 · Cited by 12
Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer
Zhang, S., Lei, R. L., Wu, J., Shan, J., Hu, Z., Chen, L., Ren, X.-C., Yao, L., Wang, J., & Wang, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.6963 · Cited by 12
“Several studies have demonstrated that BMI influences the outcomes of patients with BC and is considered a prognosis factor (32-35).”
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers
Tommasi, C., Pellegrino, B., Boggiani, D., Sikokis, A., Michiara, M., Uliana, V., Bortesi, B., Bonatti, F., Mozzoni, P., Pinelli, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700853 · Cited by 12
“org 6 the metabolic state of the organism can alter the molecular composition of a tumor (48, 80, 81, 84).”
BackgroundLiu, C., Wang, Q., Sun, B., Meng, X., Li, L., Yang, L., Cong, Y., Liu, J., Xuan, L., Huang, Y., et al. (2018) · IUBMB Life · doi:10.1002/iub.1721 · Cited by 12
Enhancing postoperative recovery with multimodal prehabilitation: the journey begins before surgery
Cho, A.-R., Vongchaiudomchoke, W., Balde, D., Kim, D. J., & Carli, F. (2025) · Korean Journal of Anesthesiology · doi:10.4097/kja.25320 · Cited by 11
High-dimensional immunotyping of tumors grown in obese and non-obese mice
Wogsland, C. E., Lien, H. E., Pedersen, L., Hanjra, P., Grøndal, S. M., Brekken, R. A., Lorens, J. B., & Halberg, N. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048977 · Cited by 11
“In addition to being associated with risk of cancer, obesity correlates with worse prognosis and higher mortality rates among breast and pancreatic cancer patients (Yuan et al., 2013; Choi et al., 2016; Chan andNorat, 2015; Calle et al., 2003; Chan et al., 2014).”
BackgroundDelay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer Survivors
Sukumar, J. S., Vaughn, J. E., Tegge, A. N., Sardesai, S. D., Lustberg, M. B., & Stein, J. S. (2022) · Cancers · doi:10.3390/cancers14051134 · Cited by 11
“For example, in a meta-analysis of 82 studies including 213,075 breast survivors, a 41% increase in mortality was demonstrated in women who were obese at the time of cancer diagnoses [8].”
MethodAccattatis, F. M., Caruso, A., Carleo, A., Console, P. D., Gelsomino, L., Bonofiglio, D., Giordano, C., Barone, I., Andò, S., Bianchi, L., et al. (2023) · Nutrients · doi:10.3390/nu15132839 · Cited by 11
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer
Muoio, M. G., PELLEGRINO, M. A., Rapicavoli, V., Talia, M., Scavo, G., Sergi, V., Vella, V., Pettinato, S., Galasso, M. G., Lappano, R., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01686-5 · Cited by 11
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer
Lammers, S. W. M., Geurts, S. M. E., van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F., et al. (2023) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkad092 · Cited by 11
Lu, S., Sun, X., Zhang, W., Li, X., Zhou, Z., Xiao, R., Lv, Q., Tang, H., Wang, B., Qu, J., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106074 · Cited by 11
Macis, D., Bellerba, F., Aristarco, V., Johansson, H. A., Guerrieri‐Gonzaga, A., Lazzeroni, M., Šestak, I., Cuzick, J. M., DeCensi, A., Bonanni, B., et al. (2024) · Nutrients · doi:10.3390/nu16132098 · Cited by 11
“However, sufficient evidence indicates that overweight and obesity increase postmenopausal breast cancer risk [9,48], regardless of when BMI is ascertained [49].”
BackgroundImproving Spatiotemporal Breast Cancer Assessment and Prediction in Hangzhou City, China
Lou, Z., Fei, X., Christakos, G., Yan, J., & Wu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03524-z · Cited by 11
Tryggvadottir, H., Rödström, M. Y., Markkula, A., Kenéz, X., Isaksson, K., Borgquist, S., & Jernström, H. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01227-6 · Cited by 11
Bell, K. E., Schmidt, S., Pfeiffer, A., Bos, L., Earthman, C. P., Russell, C., & Mourtzakis, M. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10438 · Cited by 11
Ayoub, N. M., Jaradat, S. K., Alhusban, A., & Tahaineh, L. M. (2020) · International Journal of Women s Health · doi:10.2147/ijwh.s234408 · Cited by 11
Renna, M. E., Shrout, M. R., Madison, A. A., Jaremka, L. M., Alfano, C. M., Povoski, S. P., Agnese, D. M., Carson, W. E., & Kiecolt‐Glaser, J. K. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00977-6 · Cited by 11
Salmanian, K., & Marashian, F. S. (2021) · Archives of Breast Cancer · doi:10.32768/abc.202183226-232 · Cited by 11
Ream, M. E., Saez-Flores, E., Taub, C. J., Diaz, A., Frasca, D., Blomberg, B. B., & Antoni, M. H. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705148 · Cited by 11
“Additionally, both pre- and post-menopausal OW/OB women have a greater likelihood of BC recurrence and mortality [12,13].”
BackgroundJin, X., Hu, R.-C., Guo, H., Ding, C., Pi, G., & Tian, M. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2084557 · Cited by 11
“patients, high BMI, overweight, and obesity are associated with poorer prognosis (6, 8, 27).”
BackgroundRacial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors
Bansil, S., Silva, A., Taniguchi, A., Wiedmer, C., Fernández, M. L. M., Pagano, I., Vierkoetter, K. R., Killeen, J. L., & Fukui, J. A. (2022) · The Oncologist · doi:10.1093/oncolo/oyac239 · Cited by 11
Tolonen, A., Kerminen, H., Lehtomäki, K., Huhtala, H., Barlund, M. T., Osterlund, P. J., & Arponen, O. (2023) · Cancers · doi:10.3390/cancers15133398 · Cited by 11
“High BMI may be linked with worse cancer survival outcomes, as shown in two large meta-analyses [51,52], and in a large meta-analysis of early-stage breast cancer, obesity (BMI > 30) was found to be associated with a 75% and 34% mortality increase in premenopausal and postmenopausal women, respectively [53].”
ResultBaelen, K. V., Nguyen, H.-L., Hamy, A., Richard, F., Karsten, M. M., Marta, G. N., Vermeulen, P., Toussaint, A., Reyal, F., Vincent‐Salomon, A., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.112988 · Cited by 11
Worse Breast Cancer Outcomes for Southern Nevadans, Filipina and Black Women
Callahan, K. E., Pinheiro, P. S., Cvijetic, N., Kelly, R. E., Ponce, C. P., & Kobetz, E. N. (2016) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-016-0475-2 · Cited by 11
“On the other hand, Filipinas are also more likely than other Asian groups to be obese [23], which is linked to lower breast cancer survival [25].”
BackgroundPegington, M., Adams, J. E., Bundred, N. J., Campbell, A., Howell, A., Howell, S. J., Speed, S., Wolstenholme, J. L., & Harvie, M. (2017) · Integrative Cancer Therapies · doi:10.1177/1534735416687850 · Cited by 11
Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
Do, W. L., Conneely, K. N., Gabram‐Mendola, S., Krishnamurti, U., D’Angelo, O., Miller‐Kleinhenz, J. M., Gogineni, K., Torres, M. A., & McCullough, L. E. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05605-6 · Cited by 11
Zhao, Y., Sun, Y., Ye, J., Zhang, Y., Shi, X.-B., Wang, J., Wu, H., Zhang, W., & Yao, Y. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01368-0 · Cited by 11
Zhou, C., Mo, M., Wang, Z., Shen, J., Chen, J., Tang, L., Qiu, J., Ling, Y., Ding, H., Jiang, Q., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.563566 · Cited by 11
“07 for obese and overweight women, respectively, compared with normal-weight women (8).”
BackgroundEcharri, A. A., Beresford, M. J., Campbell, J. P., Jones, R. H., Butler, R., Gollob, K. J., Brum, P. C., Thompson, D., & Turner, J. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616188 · Cited by 11
“For example, a metanalysis showed that there appears to be a linear relationship between BMI and mortality beginning from 20 kg/ m(2) when assessed before diagnosis and up to 12 months after (40).”
BackgroundTouillaud, M. S., Fournier, B., Pérol, O., Delrieu, L., Maire, A., Belladame, É., Pérol, D., Perrier, L., Préau, M., Leroy, T., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045448 · Cited by 11
Pierro, E. W., Cottam, M. A., An, H., Lehmann, B. D., Pietenpol, J. A., Wellen, K. E., Makowski, L., Rathmell, J. C., Fingleton, B., & Hasty, A. H. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3511 · Cited by 11
Oestrogen changes at menopause: insights into obesity-associated breast risk and outcomes
Sho, M., Qureshi, R., & Slingerland, J. M. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01208-7 · Cited by 10
“The excess mortality of obesity-associated breast cancer is increasingly clear 1,20,27,32 , yet insights into the underlying mechanisms have been slow to emerge.”
Rahimi, S., Ononogbu, O., Mohan, A., Moussa, D. N., Abughosh, S., & Trivedi, M. V. (2023) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01609-6 · Cited by 10
Ji, J., Yao, Y., Guan, F., Luo, L., & Zhang, G. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2237220 · Cited by 10
“Other meta-analyses have also conducted non-linear dose-response associations of BMI with survival endpoints in breast cancer and RCC (20, 22).”
BackgroundMethodSchindler, E. A., Takita, C., Collado‐Mesa, F., dos Reis, I. M., Zhao, W. K., Yang, G. R., Acosta, L. G., & Hu, J. J. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03020-3 · Cited by 10
Qin, R., Yin, L., Wang, D., Cao, X., Shaibu, Z., Wang, X., Chen, P., Sui, D., Qiu, X., & Liu, D. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241265030 · Cited by 10
McBride, K. A., Munasinghe, S. B., Sperandei, S., & Page, A. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102675 · Cited by 10
Çağlayan, D., Koçak, M. Z., Geredeli, Ç., Atçı, M. M., Tatlı, A. M., Göksu, S. S., Eryılmaz, M. K., Araz, M., & Artaç, M. (2024) · Future Oncology · doi:10.1080/14796694.2024.2402212 · Cited by 10
Guliyev, M., Alan, Ö., Günaltılı, M., Safarov, S., Fidan, M. C., Sen, G., Değerli, E., Kundaktepe, B. P., Demirci, N. S., & Papila, Ç. (2024) · Medicina · doi:10.3390/medicina60121953 · Cited by 10
Role of a Whole Plant Foods Diet in Breast Cancer Prevention and Survival
Jiménez, M. D. C. F.-F. (2025) · Journal of the American Nutrition Association · doi:10.1080/27697061.2024.2442631 · Cited by 10
Mental health consequences of weight cycling in the first-year post-treatment for breast cancer
Pila, E., Sabiston, C. M., Castonguay, A. L., Arbour‐Nicitopoulos, K. P., & Taylor, V. H. (2018) · Psychology and Health · doi:10.1080/08870446.2018.1453510 · Cited by 10
“These links between obesity and breast cancer are highly problematic, given that gains in weight pose a risk for cancer reoccurrence and cancer-related mortality (Chan et al., 2014).”
BackgroundMuscle mass loss in patients with metastatic breast cancer
Solomayer, E., Braun, E.-M., Zimmermann, J., Radosa, J. C., Stroeder, J., Endrikat, J., & Gerlinger, C. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05168-y · Cited by 10
Rasmy, A. A., & Sorour, Y. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.3.683 · Cited by 10
Skin carotenoids are inversely associated with adiposity in breast cancer survivors
Cartmel, B., Anderson, C., Irwin, M. L., Harrigan, M., Sanft, T. B., Li, F., Gellermann, W., Ermakov, I. V., & Ferrucci, L. M. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.05.012 · Cited by 10
“Carotenoids may be relevant in understanding outcomes in breast cancer survivors due to the role obesity and inflammation can play in reducing survival in this population [4, 5].”
BackgroundWang, C., Hu, K., Deng, L., He, W., Fang, F., Tamimi, R. M., & Lu, D. (2021) · BMC Cancer · doi:10.1186/s12885-021-08132-9 · Cited by 10
“, performance status [28], body mass index [29] and comorbidities [30], which may differ between individuals with multiple cancers and patients with BCa-1.”
BackgroundSaxton, J., Pickering, K., Wane, S., Crank, H., Anderson, A. S., Cain, H. J., Cohen, J., Copeland, R. J., Gray, J., Hargreaves, J., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10238-7 · Cited by 10
“Systematic review evidence shows that women who are overweight and obese at diagnosis, and those who gain weight, have poorer breast cancer survival outcomes than women of a healthy weight, irrespective of menopausal status [3].”
BackgroundWorse survival after breast cancer in women with anorexia nervosa
Bens, A., Papadopoulos, F. C., Pukkala, E., Ekbom, A., Gissler, M., & Mellemkjær, L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4618-5 · Cited by 10
“Fewer studies were included concerning underweight and mortality, and results were less clear than those for obesity [5].”
BackgroundInfluentialOptimizing Cancer Survivors’ Health: The Role of Lifestyle Behaviors
Spector, D. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2017.12.007 · Cited by 10
Hwang, K., Chu, A. J., Kim, J.-J., Lee, J. Y., Chang, J. H., Oh, S., Kim, Y. A., Jung, J., & Oh, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-34297-8 · Cited by 10
Yao Zong, Y. U. A. N., Taneja, M., & Connor, A. E. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7360 · Cited by 10
“Although the prevalence of smoking is similar between black and white women in the general population, blacks tend to initiate smoking at an older age than whites.(41,42) Our results did not demonstrate significant associations between smoking history and health outcomes among BC survivors in our study.”
ResultPalleschi, M., Iamurri, A. P., Scarpi, E., Mariotti, M., Maltoni, R., Mannozzi, F., Barone, D., Paganelli, G., Casi, M., Giampalma, E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07143-1 · Cited by 10
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women
McDonald, E. S., Gillis, L. B., Gabriel, P. E., Xapakdy, K., Young, A. J., Doucette, A. G., Schnall, M. D., Buse, J. B., & Pisano, E. D. (2026) · JCO Oncology Practice · doi:10.1200/op-26-00485 · Cited by 9
Meme Kanserinden Korunmada ve Meme Kanseri Tedavisinde Akdeniz Diyetinin Etkisi
Güneş, B. D., & Tek, N. A. (2021) · Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.46237/amusbfd.879374 · Cited by 9
Nyrop, K. A., O’Hare, E. A., Teal, R., Stein, K., Muss, H. B., & Charlot, M. (2021) · Cancer · doi:10.1002/cncr.33843 · Cited by 9
Cuomo, G., Iannone, F. P., Lorenzo, A. D., Testa, C., Ciccarelli, M., Venturini, E., Cesaro, A., Pacileo, M., Tagliamonte, E., D’Andrea, A., et al. (2023) · Clinics and Practice · doi:10.3390/clinpract13020035 · Cited by 9
“Weight loss is a goal to be achieved in all patients, since obesity, a well-known CV risk factor [67], is associated with poorer survival in patients living with cancer [68].”
BackgroundAssociation Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients
Tzschaschel, M. L. J., Friedl, T. W. P., Schochter, F., Schütze, S., Polasik, A., Fehm, T. N., Pantel, K., Schindlbeck, C., Schneeweiß, A., Schreier, J., et al. (2023) · Clinical Breast Cancer · doi:10.1016/j.clbc.2023.05.011 · Cited by 9
Benefits of Personalized Diet, Nutrition, And Exercise Programs for Cancer Survivors
Natto, H. A., Sahoo, D., & Muneera, N. (2024) · International Journal of Trends in OncoScience · doi:10.22376/ijtos.2024.2.2.12-22 · Cited by 9
Faiella, E., Vergantino, E., Vaccarino, F., Bruno, A., Perillo, G., Grasso, R. F., Zobel, B. B., & Santucci, D. (2024) · Cancers · doi:10.3390/cancers16091697 · Cited by 9
“This observation is particularly evident in reviews of literature, especially among women with breast cancer [12].”
BackgroundSheean, P., Liang, H., Schiffer, L. A., Arroyo, C., & Stolley, M. R. (2016) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0566-z · Cited by 9
“Because obesity is highly prevalent among AA women [7] and independently associated with BC progression and decreased survival [8, 9], it is considered a modifiable target to help decrease BC outcome disparities.”
Tan, X., Huang, D., Zhang, F., Zhao, Y., Tan, M., Li, H., Zhang, H., Wang, K., Li, H., Liu, D., et al. (2021) · Gland Surgery · doi:10.21037/gs-20-488 · Cited by 9
Body Composition in Women after Radical Mastectomy
Wilczyński, J., Sobolewski, P. K., Zieliński, R., & Kabała, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238991 · Cited by 9
“[36] demonstrated that obese women were at a 35% higher risk of dying from breast cancer compared to those with normal body mass.”
BackgroundImpact des facteurs nutritionnels pendant et après cancer
Ancellin, R., Cottet, V., Dossus, L., Fassier, P., Saintignon, J. G.-D., Ginhac, J., Romieu, I., Salas, S., Schneider, S. M., Srour, B., et al. (2021) · Bulletin du Cancer · doi:10.1016/j.bulcan.2021.03.001 · Cited by 9
Charvat, H., Freisling, H., Noh, H., Gaudet, M. M., Gunter, M. J., Cross, A. J., Tsilidis, K. K., Tjønneland, A. M., Katzke, V., Bergmann, M., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0688 · Cited by 9
Jin, Y. J., Kwon, M. J., Kim, J. H., Kim, J., & Choi, H. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020133 · Cited by 9
“Moreover, the number of obese individuals has increased in recent decades, and obesity has been reported to be positively associated with increased risk for both thyroid and breast cancer [14,15].”
BackgroundImpact of a randomized weight loss trial on breast tissue markers in breast cancer survivors
Dieli-Conwright, C. M., Harrigan, M., Cartmel, B., Chagpar, A. B., Bai, Y., Li, F., Rimm, D. L., Pusztai, L., Lu, L., Sanft, T. B., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00396-z · Cited by 9
The effects of exercise and diet on sex steroids in breast cancer survivors
Brown, J. C., Sturgeon, K. M., Sarwer, D. B., Troxel, A. B., DeMichele, A. M., Denlinger, C. S., & Schmitz, K. H. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0084 · Cited by 9
Jodkiewicz, M., Jagiełło-Gruszfeld, A., Surwiłło-Snarska, A., Kotowicz, B. U., Fuksiewicz, M., & Kowalska, M. M. (2022) · Nutrients · doi:10.3390/nu14122541 · Cited by 9
“The literature data also indicate an increased risk of breast cancer deaths in obesity [13,14].”
BackgroundSalmanian, K., & Marashian, M. S. (2022) · Clinical Social Work and Health Intervention · doi:10.22359/cswhi_13_5_12 · Cited by 9
Taroeno‐Hariadi, K. W., Putra, Y. R., Ariesta, N. F., Sinorita, H., Hardianti, M. S., Widodo, I., & Aryandono, T. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.9.3157 · Cited by 9
“Our results showed concordance with Saleh et al. (2021) and contrasted with a meta-analysis of 82 follow-up studies (Chan et al., 2014).”
ResultMurakami, Y., Matsumoto, K., Ikeda, M., Utsunomiya, T., Hirayama, T., Koguchi, D., Matsuda, D., Okuno, N., Taoka, Y., Irie, A., et al. (2018) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12848 · Cited by 9
Fadelu, T. A., Damuse, R., Lormil, J. K., Pecan, E., Greenberg, L., Dubuisson, C., Pierre, V., Triedman, S. A., Shulman, L. N., & Rebbeck, T. R. (2020) · JCO Global Oncology · doi:10.1200/go.20.00307 · Cited by 9
“In large international systematic meta-analyses, overweight and obesity are associated with higher disease recurrence, higher overall mortality, and higher breast cancer–specific mortality.(14,15) Nonetheless, the impact of increased weight on breast cancer outcomes remains understudied in populations of African desce…”
BackgroundJiang, Y., Xie, Q., & Chen, R. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.06.010 · Cited by 9
Franzoi, M. A., Lambertini, M., Ceppi, M., Bruzzone, M., & de Azambuja, E. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06525-3 · Cited by 9
“In addition, overweight and obesity are factors associated with a worse prognosis after BC diagnosis [2, 3].”
BackgroundPichardo, M. S., Sanft, T. B., Ferrucci, L. M., Romero-Ramos, Y. M., Cartmel, B., Harrigan, M., Velázquez, A. I., Fayanju, O. M., Winer, E. P., & Irwin, M. L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1079293 · Cited by 9
“Soltero 2022 (22), Arizona (Physical Activity) RCT, 2-arm, pilot Group (N): 20 Arm 1(10); Arm 2 (10) Sample: Survivors -65% Latina -25% Non-Hispanic White -5% Black -5% Mixed race/ethnicity Stages: 0-III Mean time since diagnosis: 2 wks to 10 y past primary treatment Mean age: Arm 1 (49.”
BackgroundActivité physique et nutrition après diagnostic d’un cancer
Bachmann, P., Foucaut, A.-M., Baudinet, C., Meyrand, R., Kempf-Lépine, A.-S., Berthouze, S., Fervers, B., & Touillaud, M. S. (2014) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2014.10.007 · Cited by 9
D’Aiuto, M., Chirico, A., Riggi, M. A. D., Frasci, G., Laurentiis, M. D., Bonito, M. D., Vici, P., Pizzuti, L., Sergi, D., Maugeri‐Saccà, M., et al. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1156265 · Cited by 9
Obezitenin kadın kanserleri üzerindeki etkileri: derleme makalesi
GÜNALDI, O., Bozkurt, H. S., İlter, E., Günaldı, A., & Çelik, A. (2019) · Maltepe Tıp Dergisi · doi:10.35514/mtd.2019.19 · Cited by 9
“Araştırmacılara göre bu gruptaki hastaların normal kilolu olanlara göre, kansere bağlı ve genel mortaliteleri %30 oranında daha fazladır (50).”
(2022) · PubMed · doi:10.48252/jcr57 · Cited by 8
Teng, Y.-T., Wang, Y. A., Dong, Y., & Liu, J. J. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07280-3 · Cited by 8
Talat, L. Y., Mohamed, G., Ibraheem, M. H., WalyEldeen, A. A., Hassan, H., & Ibrahim, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-17638-2 · Cited by 8
“The inclusion criteria were as follows: Adult female patients aged ≥ 18 years, obese with BMI > 30, and pathologically confirmed primary breast cancer, stage I-III (non-metastatic).”
InfluentialYun, J., Seo, J., Koh, J., Im, S., Hong, K. Y., Son, Y., Jeong, D., Fukuda, J., Park, J., & Chun, Y. (2025) · Advanced Science · doi:10.1002/advs.202515186 · Cited by 8
Endothelial dysfunction determines vascular mechanisms of metastatic progression in breast cancer
Mirzaeva, M., Mirzayev, A., Iriskulov, B., Бахадировна, А. С., Nizamkhodjaev, S., & Asrorov, A. M. (2026) · Discover Oncology · doi:10.1007/s12672-026-04437-y · Cited by 8
Impact of Obesity on Outcomes of Operable Breast Cancer: A Retrospective Cohort Study
Engkakul, T., Thnogtang, N., Nimmannit, A., Chuthapisith, S., & Akewanlop, C. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.4.953 · Cited by 8
“However, several studies from Belgium (de Azambuja et al., 2010), Denmark (Ewertz et al., 2011), Japan (Kawai et al., 2016), including the most recent systematic review (Chan et al., 2014) suggested that obesity was associated with poorer outcome in breast cancer patients.”
BackgroundResultFatigue and Its Contributing Factors in Chinese Patients with Primary Pituitary Adenomas
Zhang, X., Li, Y., Zhang, D., Zhong, Y., & Li, T. X. (2023) · Journal of Oncology · doi:10.1155/2023/9876422 · Cited by 8
Insulin receptor loss impairs mammary tumorigenesis in mice
Podmore, L., Poloz, Y., Iorio, C., Mouaaz, S., Nixon, K., Smirnov, P., McDonnell, B., Lam, S. H. L., Zhang, B., Tharmapalan, P., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113251 · Cited by 8
Aktaş, A., Greiner, R. S., Flores, M., Boselli, D. M., Stone, T. J., Wang, E. W., Hadžikadić-Gušić, L., Wallander, M. L., Hecksher, A., Bailey-Dorton, C. M., et al. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.10.014 · Cited by 8
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
Gilcrease, M. Z. (2016) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2016.04.019 · Cited by 8
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.